RETRACTED: The antibody zalutumumab inhibits epidermal growth factor receptor signaling by limiting intra- and intermolecular flexibility.
about
Polyhedral 3D structure of human plasma very low density lipoproteins by individual particle cryo-electron tomography1.Antibodies to watch in 2010Human epidermal growth factor receptor (HER1) aligned on the plasma membrane adopts key features of Drosophila EGFR asymmetry.Rash rates with egfr inhibitors: meta-analysis.High-Throughput Screening for Internalizing Antibodies by Homogeneous Fluorescence Imaging of a pH-Activated Probe.EGFR-Targeting as a Biological Therapy: Understanding Nimotuzumab's Clinical EffectsNovel human antibody therapeutics: the age of the Umabs.Interaction of antibodies with ErbB receptor extracellular regions.Sensitivity and resistance to EGF-R inhibitors: approaches to enhance the efficacy of EGF-R antibodies.Targeted therapy for malignant glioma patients: lessons learned and the road ahead.Targeting the EGF receptor ectodomain in the context of cancer.Potential of ErbB4 antibodies for cancer therapy.Targeting the epidermal growth factor receptor in solid tumor malignancies.Early investigational drugs that target epidermal growth factor receptors for the treatment of head and neck cancer.An open-label single-arm, phase II trial of zalutumumab, a human monoclonal anti-EGFR antibody, in patients with platinum-refractory squamous cell carcinoma of the head and neck.Molecular dynamics simulations of transitions for ECD epidermal growth factor receptors show key differences between human and drosophila forms of the receptors.Anti-EGFR Agents: Current Status, Forecasts and Future Directions.Complement-mediated tumor-specific cell lysis by antibody combinations targeting epidermal growth factor receptor (EGFR) and its variant III (EGFRvIII).
P2860
Q30152743-DCD236DE-1A56-4B95-956B-4997306B07EDQ33688243-76208B5A-3F54-42EF-88A0-C9E7B559E527Q34133387-030EB4D4-3E75-4EA1-825D-88340CBCA510Q34761646-E7AA0064-D7AB-4929-B4FD-AD194E0727FDQ35827605-987DF686-8F46-4814-92F6-06F8706376D1Q37132708-FF42A559-3AB9-4AD4-9D21-CF6980F1C37EQ37243228-C469CFAB-5D22-4ABE-95B7-BCD4CCCFEC3BQ37320814-6BE831ED-BB63-4CD9-A075-EC0675C65839Q37468539-29030F51-DB95-424C-B9BE-2285ABFD6851Q37533648-5D0852AA-0425-4D51-B604-97FA22917A74Q37600910-A2AEDF9D-7939-4C08-9C96-D17B4415E3E5Q37658764-4BFEEF0F-236C-4BDE-9DEA-5A8E06E970B2Q37990044-1B466D19-4E15-4C0D-8C97-3A411DE4240AQ38240998-198F8554-2B74-4B91-9A0B-A0B57DF8B06CQ38432573-B3DE3207-0F79-4C27-98CA-C2E039DC37BDQ38548814-3833A0C2-FD49-4B76-AECF-1CE1587C6FD8Q38832105-45DD01E7-84FB-46E1-8543-B83B3954F50DQ39515308-074A6707-F59F-4E60-B58F-60B1291E75EB
P2860
RETRACTED: The antibody zalutumumab inhibits epidermal growth factor receptor signaling by limiting intra- and intermolecular flexibility.
description
2008 nî lūn-bûn
@nan
2008 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
name
RETRACTED: The antibody zalutu ...... nd intermolecular flexibility.
@ast
RETRACTED: The antibody zalutu ...... nd intermolecular flexibility.
@en
type
label
RETRACTED: The antibody zalutu ...... nd intermolecular flexibility.
@ast
RETRACTED: The antibody zalutu ...... nd intermolecular flexibility.
@en
altLabel
The antibody zalutumumab inhib ...... and intermolecular flexibility
@en
prefLabel
RETRACTED: The antibody zalutu ...... nd intermolecular flexibility.
@ast
RETRACTED: The antibody zalutu ...... nd intermolecular flexibility.
@en
P2093
P2860
P356
P1476
RETRACTED: The antibody zalutu ...... nd intermolecular flexibility.
@en
P2093
Anne von Euler
Annika Brännström
Jan G J van de Winkel
Jeroen J Lammerts van Bueren
Magnus Jansson
Matthias Peipp
Paul W H I Parren
Tanja Schneider-Merck
Thomas Valerius
Wim K Bleeker
P2860
P304
P356
10.1073/PNAS.0709477105
P407
P577
2008-04-21T00:00:00Z